BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11319598)

  • 1. Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy.
    Rosen O; Massenkeil G; Hiepe F; Pest S; Hauptmann S; Radtke H; Burmester G; Thiel A; Radbruch A; Heymer B; Arnold R
    Bone Marrow Transplant; 2001 Mar; 27(6):657-8. PubMed ID: 11319598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation.
    Clements PJ; Furst DE
    J Rheumatol Suppl; 1997 May; 48():85-8. PubMed ID: 9150125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations.
    Henes JC; Schmalzing M; Vogel W; Riemekasten G; Fend F; Kanz L; Koetter I
    J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells.
    Tsukamoto H; Nagafuji K; Horiuchi T; Mitoma H; Niiro H; Arinobu Y; Inoue Y; To K; Miyamoto T; Iwasaki H; Teshima T; Harada M; Akashi K
    Rheumatology (Oxford); 2011 May; 50(5):944-52. PubMed ID: 21172925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.
    Saccardi R; Tyndall A; Coghlan G; Denton C; Edan G; Emdin M; Farge D; Fassas A; Finke J; Furst D; Lassus M; Mancardi G; Miniati I; Mini E; Pagliai F; Passweg J; Pignone A; van Laar JM; Bocelli-Tyndall C; Matucci-Cerinic M
    Bone Marrow Transplant; 2004 Nov; 34(10):877-81. PubMed ID: 15517007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.
    Oyama Y; Barr WG; Statkute L; Corbridge T; Gonda EA; Jovanovic B; Testori A; Burt RK
    Bone Marrow Transplant; 2007 Sep; 40(6):549-55. PubMed ID: 17646844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
    Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
    Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
    Burt RK; Milanetti F
    Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult stem cell treatment of scleroderma.
    Tyndall A; Furst DE
    Curr Opin Rheumatol; 2007 Nov; 19(6):604-10. PubMed ID: 17917542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression.
    Bohgaki T; Atsumi T; Bohgaki M; Furusaki A; Kondo M; Sato-Matsumura KC; Abe R; Kataoka H; Horita T; Yasuda S; Amasaki Y; Nishio M; Sawada K; Shimizu H; Koike T
    J Rheumatol; 2009 Jun; 36(6):1240-8. PubMed ID: 19447934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations.
    Henes JC; Koetter I; Horger M; Schmalzing M; Mueller K; Eick C; Bauer A; Vogel W; Kanz L
    Rheumatology (Oxford); 2014 May; 53(5):919-22. PubMed ID: 24459219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis.
    Martini A; Maccario R; Ravelli A; Montagna D; De Benedetti F; Bonetti F; Viola S; Zecca M; Perotti C; Locatelli F
    Arthritis Rheum; 1999 Apr; 42(4):807-11. PubMed ID: 10211898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring?
    Burt RK; Oyama Y; Traynor A; Quigley K; Brush M; Rodriguez J; Barr WG
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S65-7. PubMed ID: 12931246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
    Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
    Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.
    Villela L; Sureda A; Canals C; Sanz MA; Martino R; Valcárcel D; Altés A; Briones J; Gómez M; Brunet S; Sierra J
    Haematologica; 2003 Mar; 88(3):300-5. PubMed ID: 12651269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Causes of death of patients with systemic sclerosis].
    Chwieśko S; Sierakowski S; Kowal-Bielecka O
    Pol Merkur Lekarski; 2006 Oct; 21(124):341-4. PubMed ID: 17205772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem cell transplantation for systemic sclerosis.
    Farge D; Nash R; Laar JM
    Autoimmunity; 2008 Dec; 41(8):616-24. PubMed ID: 18958754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.